Raphael Gorodetsky is the head of the Laboratory of Biotechnology and Radiobiology at the Sharett Institute of Oncology, Hadassah - Hebrew University Medical Center in Jerusalem, where he is employed as a faculty member since 1989 (affiliated to the Hebrew University Medical School in Jerusalem). He received his M.Sc. and Ph.D. from the Hebrew University in 1985 and had his Postdoc at UCLA Medical Center (1985-1988). Among other subjects, he was involved in cancer research and radiobiology studies, as well as in projects in regenerative medicine. His earlier studies were associated with trace elements physiology in health and disease. Later directions of his research focused mainly on the invention of fibrin-based biomaterials used for tissue regeneration and cell therapies and on different aspects of cancer research and radiation biology. Among the new ventures he co-founded was Hapto Biotech in 2000, where he served as the chief scientist (later merged with Ortec to form Forticel International, NY).